Leukemia Clinical Trials

Showing 3641-3660 of 10,987 trials

Levita Magnetic Grasper Device Safety and Performance Study

NCT02049983

The purpose of this study is to determine the Levita Magnetic Grasper Device Safety and Performance in Laparoscopy.

Levita Magnetics50 participantsStarted Jan 2014

Santiago, Santiago Metropolitan, Chile • Santiago, Santiago Metropolitan, Chile • Santiago, Santiago Metropolitan, Chile

No Longer Available

Expanded Access to Provide GL-ONC1 for the Treatment of Advanced Cancers With No Standard of Care

NCT03420430

GL-ONC1 expanded access is for patients who are ineligible for an ongoing GL-ONC1 clinical trial. Expanded access is intended to treat individual patients with advanced stage cancers, including blood cancer, with no standard of care options for treatment. Potential patients will be evaluated individually depending on GL-ONC1 product supply.

Advanced Stage Cancer (Solid Tumor Disease for 4 Patients)Acute Myeloid Leukemia (6 Patients)

Genelux Corporation

Orlando, Florida, United States

COMPLETEDPhase 1/2

A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China

NCT03565003

This is a Phase 1/2a, open-label, multi-center study of JAB-3068 in Patients with advanced solid tumors.This study has two phases: dose escalation phase and dose expansion phase.

Non-small Cell Lung CancerHead and Neck CancerEsophageal Cancer+1 more

Jacobio Pharmaceuticals Co., Ltd.126 participantsStarted Nov 2018

Beijing, Beijing Municipality, China • Beijing, Beijing Municipality, China • Beijing, Beijing Municipality, China +1 more locations

COMPLETEDPhase 2

Icotinib for Completed Resected IB NSCLC With EGFR Mutation

NCT02264210

This phase II trial studies how well icotinib works in treating patients with completely resected stage IB NSCLC harboring EGFR mutation.

Lung NeoplasmsSquamous Cell Lung CancerAdenocarcinoma of the Lung+4 more

Sun Yat-sen University128 participantsStarted Jan 2015

Guangzhou, Guangdong, China

Levita Magnetic Grasper Device Safety and Performance Study

Expanded Access to Provide GL-ONC1 for the Treatment of Advanced Cancers With No Standard of Care

A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China

Icotinib for Completed Resected IB NSCLC With EGFR Mutation

Related Searches

BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma.

Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer

Diagnostic Performance of Dual Energy CT for the Detection of Gallbladder Gallstones

Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia

STR + Anti PD-1 Therapy in Patients with Locally Advanced Unresectable Pancreatic Adenocarcinoma

ALK Tyrosine Kinase Inhibitors in ALK-rearranged Advanced Squamous Cell Carcinoma

Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)

Docetaxel - Carboplatin As Second Line Treatment in Patients with Small Cell Lung Cancer

Sunvozertinib Plus Anlotinib as 1L Treatment in EGFR Mutant Advanced NSCLC-RW

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Ischemic Cerebral Vascular Disease (CBSinICVD)

Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia

Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC

Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy

Phase II Clinical Trial to Evaluate the Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Capsule and Chemotherapy in the Treatment of Immunoresistant Advanced Non-small Cell Lung Cancer

Clinical Registration Study of Haplo-HSCT for Elderly Patients With Acute Leukemia/ Myelodysplastic Syndrome

APOLLO: Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation